N.N. Petrov National Medicine Research Center of oncology. Ph. d. urology
Saint Petersburg, Russia
Joined May 2012
- Tweets1.2K
- Following753
- Followers150
- Likes96
Eldar Mamizhev retweeted
▸ Delay beyond 3 months to partial nephrectomy linked to higher cancer mortality in younger patients
This evening on UrologyWatch, Oct 16: urologywatch.com
Eldar Mamizhev retweeted
Great tutorial. As an old-timer who still performs open surgery, I’m surprised by the clipless approach. I prefer to clip the major lymphatic vessels. Who else? #urology
🔬 Pelvic lymph node dissection: let's focus on the LEFT side!
Most surgical tutorials focus on the right side. But what about the left?
🎓 In this new FREE Surgical Vision tutorial, you'll learn:
✅ Key anatomical landmarks
✅ Instrument positioning
✅ External iliac vein dissection
✅ How to safely identify and preserve the obturator nerve
Relevant to both prostate and bladder cancer surgery.
🔁 Subscribe & share to help make surgical education accessible to everyone!
@ERUSrobotics @AmerUrological @Uroweb
youtu.be/vP_Qsfc7frE
Eldar Mamizhev retweeted
Enblock resection of bladder tumor with holmium
youtu.be/Gr9WytM-orw?si=3saI…
En bloc resection of bladder tumours can be particularly useful for lesions at the bladder dome, where a TUR loop may make controlled resection with an adequate deep muscle biopsy challenging.
Holmium or thulium fibre laser allows precise depth control—reported down to 0.1 mm. Sharing a video of the en bloc resection of an exactly 2 cm tumour located at the bladder dome.
youtu.be/Gr9WytM-orw?si=3saI…
Eldar Mamizhev retweeted
Delighted to share our latest publication!
Nerve-sparing prostatectomy is well established, yet ED after RP remains common.
The idea of arterial-sparing RP is not new, but traditionally relies on intraoperative identification of accessory pudendal arteries.
Could preoperative mpMRI guide arterial preservation?
Our study suggests potential.
bjui-journals.onlinelibrary.…
@uclh @vonstampy @alnowfal @drmegson @donwglee @ucl
Eldar Mamizhev retweeted
Intraperitoneal laparoscopic radical prostatectomy with @MAlKhameesMD
Montsouris technique with left-sided nerve sparing and right-sided extracapsular dissection.
Thanks to @Aldughiman_MD and @sbinhamrii for all the support at @SMCH_Riyadh and for the amazing assistance of @DrIbrahimTaha1.
Eldar Mamizhev retweeted
Nerve-Spearing Laparoscopic Radical Prostatectomy #HospitalLaPaz #prostatecancer #laparoscopy @JGomezRivas @malvarezmaestro @ResidentesAEU
Eldar Mamizhev retweeted
“Ultrapreservative robotic radical prostatectomy: anterior access”
📺 Watch the full video: irc.ad/xr9O
In this lecture, Prof. Thierry Piechaud shares his expertise on ultrapreservative robotic radical #prostatectomy using an anterior access approach.
Eldar Mamizhev retweeted
⚡️ Bladder cancer global overview (GLOBOCAN 2022): 614,298 new cases and 220,596 deaths worldwide. ~75% of the burden in males.
Highest incidence rates in Europe, particularly southern and northern regions. Mortality declining in many high-income countries.
doi.org/10.1016/j.eururo.202…
#BladderCancer @EuropeanUrology
Eldar Mamizhev retweeted
🔍 Surgical anatomy challenge!
Can you identify all the key anatomical structures in this teaser of a left-sided pelvic lymph node dissection? 🧐
💬 Drop your answers in the comments!
🎬 Coming soon on Surgical Vision: A step-by-step tutorial on left-sided pelvic lymph node dissection.
🔔 Subscribe to discover the answers and learn more!
🔗 youtube.com/@surgical.vision
Eldar Mamizhev retweeted
Find out why this article is one of our most-read articles of the past 30 days! 👇
🔬Individualized Oncologic Surveillance After Radical Prostatectomy for Localized Prostate Cancer by Francesco Pellegrino et al
Article on website: buff.ly/qhSmWo7
👏We thank the authors for publishing your work in EUO.
@uroweb
@mroupret
@GPloussard
@jteoh_hk
@Ric_Campi
@CaPsurvivorship
@LauraMarandino
@DaveDandrea
@RenuEapen
@Ecastromarcos
@OncoAlert
@Sciencedirect
Eldar Mamizhev retweeted
Lymphocele cited as major reason in guidelines to avoid LND in prostate cancer. Here we show most almost all lymphoceles (42/43) come from Cloquet's node, which should not be removed during LND. auajournals.org/doi/10.1097/…
Eldar Mamizhev retweeted
Traumatic catheterization is a reason to postpone intravesical BCG. BCG contains live, attenuated mycobacteria. If catheterization leaves the bladder lining bleeding, they can spread beyond the bladder and cause systemic infection.
Visible hematuria and symptomatic UTI are also contraindications. Microscopic hematuria or an asymptomatic positive culture alone aren't, according to EAU.
Ref: EAU Guidelines on Non-muscle-invasive Bladder Cancer 2026; US prescribing information, TICE BCG
#BladderCancer #BCG
Eldar Mamizhev retweeted
Histologic diversity in #BladderCancer is stage-dependent: rare in pTa (<2%) and pT1 (<5%), but common in MIBC/mUC (~35% variants/divergent). Squamous differentiation dominates (~90% of divergent cases), with basal-like biology and distinct therapeutic targets.
#GUPath #UrothelialCancer
🌶️🌡️Summary of my uropathology for urologists and oncologists series! 👉check it out! and retweet if you like!
@urotoday @OncoAlert @Uroweb @EAUYAUrology @EAU_YAUroTech @EauPatient @niklas_kluemper @onkowissen
xitter.cf/Markuseckstein3/status…
Eldar Mamizhev retweeted
Pelvic node dissection gives the most accurate staging available, but neither randomized trial moved PSA relapse. The review from @AshTewariMD's department argues those nodes are where T cells get primed.
xitter.cf/WenchangYue/status/210…
Eldar Mamizhev retweeted
An introduction to MIBC (and mUC) in graphical narrative abstract. Please note: there are more subtype/variant histologies (there will be a separate thread in this).
🌶️🌡️Summary of my uropathology for urologists and oncologists series! 👉check it out! and retweet if you like!
@urotoday @OncoAlert @Uroweb @EAUYAUrology @EAU_YAUroTech @EauPatient @niklas_kluemper @onkowissen
xitter.cf/Markuseckstein3/status…
Eldar Mamizhev retweeted
Repetition rewires the brain.
Neuroplasticity doesn't decipher between good and bad.
You do.
